Syzygium jambolanum 1X (Paramesh Banerji Life Sciences LLC)
Welcome to the PulseAid listing for the Syzygium jambolanum 1X drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Paramesh Banerji Life Sciences LLC |
NON-PROPRIETARY NAME: | Syzygium jambolanum |
SUBSTANCE NAME: | SYZYGIUM CUMINI SEED |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2015-06-05 |
END MARKETING DATE: | 0000-00-00 |
Syzygium jambolanum 1X HUMAN PRESCRIPTION DRUG Details:
Item Description | Syzygium jambolanum 1X from Paramesh Banerji Life Sciences LLC |
LABELER NAME: | Paramesh Banerji Life Sciences LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1([hp_X]/8mL) |
START MARKETING DATE: | 2015-06-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69152-1553_17c2c1b4-bf21-6e61-e054-00144ff8d46c |
PRODUCT NDC: | 69152-1553 |
APPLICATION NUMBER: | |
Other SYZYGIUM CUMINI SEED Pharmaceutical Manufacturers / Labelers: